Abstract
Bisphosphonates comprehend a class of stable synthetic compounds that have a potent inhibition of bone resorption and have a high affinity for bone tissue hydroxyapatite. These are considered the drugs of choice for the treatment of osteolytic disorders such as multiple myeloma and bone metastases of breast and prostate cancer. However prolonged use of these drugs may induce the onset of …